Thaiss · Cell 2016 · preclinical mechanistic and multi-omics study · n=?

Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations.

Cited 883 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical laboratory study using multi-omics and imaging models without human clinical data.

PubMed 27912059 · doi:10.1016/j.cell.2016.11.003 · record verified 2026-08-30

What was done

Integrated multi-omics and imaging approaches were used to investigate diurnal compositional, metabolomic, and biogeographical localization patterns of the gut microbiota. Researchers examined how these rhythmic microbial dynamics influence host circadian chromatin, transcriptional, and metabolite oscillations in the intestine and liver, as well as the downstream consequences of disrupting normal microbiome rhythmicity.

What was found

The abstract reports no numerical values or effect sizes. It reports that the gut microbiota displays daily oscillations in biogeographical localization and metabolite production, which rhythmically expose the intestinal epithelium to bacterial species and metabolites. This microbial behavior drives host circadian epigenetic, transcriptional, and metabolic programming. Disruption of homeostatic microbiome rhythms abrogated normal chromatin and transcriptional oscillations while inducing de novo genome-wide oscillations in the intestine and liver, altering diurnal host physiology.

Why it matters

It establishes a mechanistic bridge between the gut microbiome and host circadian rhythmicity, demonstrating that microbial diurnal dynamics globally regulate host epigenetic and transcriptional programs.

Limits

The study is entirely preclinical with no human clinical evaluation. The abstract does not report specific sample sizes, animal strains, statistical metrics, effect sizes, or specific disease phenotypes tested.

Cited by